EASyM Executive Board
Prof. Dr. Charles Auffray
Research Director at the CNRS Institute of Biological Sciences
Founder of the European Institute for Systems Biology & Medicine (EISBM), Lyon, France
I am fostering the transition from reactive to proactive Systems P4 Medicine through the EISBM-ISB Pioneers of Health and Welness Project initiated in 2014. It forms the basis for a worldwide network of Systems Biomedicine Centres in which Europe can and must play a leading role through Horizon 2020 and beyond. I am committed to the implementation of the strategic vision built over the past decade through a number of foundational EU-funded Systems Biomedicine projects Union and developed in the framework of CASyM through the EASyM by acting as its Chair.
Prof. Dr. Timothy R.D.J. Radstake
Director of the Utrecht Infection & Immunity FOCIS center of excellence
University Medical Center Utrecht, the Netherlands
It is time for a change. As clinician scientists we have to get rid of the silo’s on which basis we treat patients but also perform research. Also, we should move from a reductionist’s way of performing research to a more holistic approach if we want to understand health and disease. The only way to do so is to utilize a systems medicine approach not only for understanding disease but also to develop biomarkers for treatment, side effects and the execution of effective Phase I – III clinical trials.
Prof. Dr. Anna Norrby Teglund
Head of Center for Infectious Medicine at Karolinska Institute
Coordinator of INFECT, an FP7 EU-project in systems medicine
In order ot further develop and fully implement systems medicine, there is a need for collaborative networks between pre-clinical and clinical researchers and the creation of true translational centers. This is challenging as it involves different organizational entitites (hospital, research institutes, universities) with different defined tasks/responsibilites in society.
Mr. David Supple
Director of consultancy firm, involved in the field of information management, security and compliance
Background in public sector work, utilising big data for primary care
Chair of the Patient Input Platform for U-BIOPRED
From the patient perspective, my vision for systems medicine is to ultimately provide a personalised, collaborative and integrated pathway for service delivery that encompasses a risk-based predictive care model to deliver early, cost-effective, low impact interventions for patients. I want patients to be data aware, and to ‘own’ their relationship with systems medicine, not to let it become an analysis tool that is wielded against the patient, so that they can work with the science and the technology in partnership to the benefit of their long-term health.
Communication, Outreach & Recruitment Officer
Prof. Dr. Alfredo Cesario
Research Manager (Head, Office for International Research Activities and Systems Medicine) at IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
Member of the Board of the European Forum for Good Clinical Practice (www.efgcp.eu)
As a clincial researcher, I am set at the core of the principles driving investments in funding for Systems Medicine, this being the validation of Systems Medicine approaches into the clinical trials; design (and therefore regulatory dossiers), Systems Medicine based. My main goal, is to present and promote the Society as its Communication and Outreach Officer.
Education and Professional Development Officer
Prof. Dr. Damjana Rozman
Professor of Biochemistry and Molecular Biology and Head of the Centre for Functional Genomics and Bio-Chips, Faculty of Medicine, University of Ljubljana, Slovenia
Representative of Slovenia in the Board of the ESFRI infrastructure ELIXIR
To achieve a broader acceptance and inclusion of systems principles in medical education already on the masters’ level, the partnership with Association of Medical Schools in Europe (AMSE) and European Association of Medical Students (EAMS) should be among priority goals. EASyM should initiate also efforts towards the European Systems Medicine doctorate.
A strategy is also needed for the lifelong education and outreach of systems medicine to medical doctors in practice. Here EASM should catalyse connections to major disease-oriented medical associations and suggest systems medicine based lectures, workshops or tutorials adjoined to clinical research meetings.
International Project & Funding Officer
Prof. Dr. Mikael Benson
Professor of Pediatrics, Centre for Individualised Medicine, Linköping University, Sweden
Deputy chair of the steering committee of CASyM
Clinical Implementation for predictive and individualised medicine based on a network-based strategy that combines omics, computational, functional and clinical studies. I believe we will see the first clinical implementations, for individualised medicine, in severe diseases with costly treatments. This will entail developing Clinical Decision Support Systems that integrate omics and clinical routine data, as well as huge training efforts. The next step will be predictive medicine (within 10 years). A likely development is transformation of health care to focus on predictive medicine based on repeated, partly automated checks up. This will entail development of electronic medical health devices as well as nanotechnological diagnostic devices.
Support staff to the Executive Board
Assist. Prof. Dr. Jure Acimovic
Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Slovenia
Dr. Maria Manuela Nogueira
European Institute of Systems Biology and Medicine (EISBM), Lyon, France
Dr. Robert Schwamborn
Systems Biology Ireland (SBI), University College Dublin, Ireland
In order to contact the EASyM Executive Board, please send an email to email@example.com